Clinical Trial Update: PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis [Phase 2]

View source ↗

Summary

Phase 2 dose-range finding study update for PURETHAL mites in patients with persistent allergic rhinitis or rhinoconjunctivitis; the trial (NCT01438463) has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Allergic Rhinoconjunctivitis

Drugs mentioned

• PURETHAL Mites (house dust mite extract)

Snippet

Sponsor: HAL Allergy | Conditions: Allergic Rhinitis, Allergic Rhinoconjunctivitis | Phase 2 | Status: COMPLETED